ETFS Holding Sequenom, Inc.

 
Stock Quotes for Sequenom, Inc. top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for sqnm investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for sqnm investment picks

 
News Articles for Sequenom, Inc. top ^
2013/3/7
Diagnostic Services Now Largest Contributor to Total Revenues SAN DIEGO , March 7, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) , a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $33.7 million and $89.7 million for the fourth quarter and full year of 2012, respectively.
Sign-up for Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year Of 2012 investment picks
2013/3/5
SAN DIEGO , March 5, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) , a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Barclays Global Healthcare Conference at the Loews Miami Hotel in Miami, FL on March 12-14, 2013 .
Sign-up for Sequenom Announces Participation At The Barclays Global Healthcare Conference investment picks
2013/2/4
SAN DIEGO , Feb.
Sign-up for Sequenom CMM's MaterniT21 PLUS LDT Now Reporting On Gender-Specific Chromosomal Abnormalities investment picks
2013/2/20
SAN DIEGO , Feb.
Sign-up for Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2012 Financial Results And Conference Call investment picks
2013/3/15
SAN DIEGO , March 15, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) , a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the 25 th Annual Roth Conference at the Ritz-Carlton Hotel in Laguna Niguel, CA on March 17-20, 2013 .
Sign-up for Sequenom Announces Participation At The 25th Annual Roth Conference investment picks
2013/3/21
SAN DIEGO , March 21, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) , a life sciences company providing innovative genetic analysis solutions, today announced that Sequenom Center for Molecular Medicine (SCMM) has launched an advanced new cystic fibrosis carrier screen test branded under the name Heredi-T™.  The laboratory-developed test (LDT) is now available as a testing service to ordering physicians.
Sign-up for Sequenom, Inc. Announces The Availability Of Heredi-T™ Cystic Fibrosis Carrier Screening LDT Through Sequenom CMM investment picks
2013/4/16
SAN DIEGO , April 16, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) , a life sciences company providing innovative genetic analysis solutions, today announced that earlier this month, its wholly owned subsidiary, the Sequenom Center for Molecular Medicine (Sequenom CMM),  surpassed 100,000 MaterniT21™ PLUS test samples processed since the launch of its laboratory developed test (LDT) in October of 2011.
Sign-up for Sequenom CMM Achieves Milestone Of 100,000 MaterniT21™ Plus Tests Processed investment picks
2013/4/25
SAN DIEGO , April 25, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) , a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the first quarter of 2013 after closing of the NASDAQ Global Market on Thursday, May 9, 2013 .
Sign-up for Sequenom, Inc. Announces Date of First Quarter 2013 Financial Results and Conference Call investment picks
2013/5/9
158% Year-Over-Year Increase In Total Revenues Led By Continued Growth In Diagnostics Sales Volumes SAN DIEGO , May 9, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) , a life sciences company providing innovative genetic analysis solutions, today reported revenue of $38.5 million for the first quarter of 2013, an increase of 158% compared to revenue of $14.9 million for the first quarter of 2012.
Sign-up for Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013 investment picks
2013/5/8
SAN DIEGO , May 8, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) , a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Bank of America Merrill Lynch Health Care Conference at the Encore at the Wynn Hotel in Las Vegas, NV on May 14-16, 2013 .
Sign-up for Sequenom Announces Participation At The Bank Of America Merrill Lynch Health Care Conference investment picks
2013/5/28
SAN DIEGO , May 28, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) , a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Jefferies 2013 Global Healthcare Conference at the Grand Hyatt in New York, NY on June 3-6, 2013 .
Sign-up for Sequenom Announces Participation At The Jefferies Global Healthcare Conference investment picks
2013/5/31
ADVISORY, May 31, 2013 (GLOBE NEWSWIRE) -- What: Sequenom, Inc. [SQNM], a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions, will visit the NASDAQ MarketSite in Times Square.
Sign-up for Sequenom, Inc. [SQNM] to Ring The NASDAQ Stock Market Opening Bell investment picks
2013/5/30
SAN DIEGO and ST OUEN L'AUMONE, France , May 30, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) , a life sciences company providing innovative genetic analysis solutions, today announced that it, along with its wholly owned subsidiary, Sequenom Center for Molecular Medicine (Sequenom CMM), has entered into technology licensing and marketing agreements with Laboratoire Cerba in France for noninvasive prenatal aneuploidy testing.
Sign-up for Sequenom Announces License And Marketing Agreements With Laboratoire Cerba In France investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

ETFS Holding Sequenom, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  Market Cap |  Industry

Previous: ETFS Holding Semtech Corporation  |  Next: ETFS Holding Severn Trent PLC